ChristopherGAzzoliMDFASCO
Oncology • Providence, RIThoracic Cancer
Director of Thoracic Oncology, Lifespan Cancer Institute; Associate Professor of Medicine, Brown University
Dr. Azzoli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lifespan Cancer Institute
593 Eddy Street, George 362
Providence, RI 02903Fax+1 401-444-4184
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
RI State Medical License 2018 - 2026
MA State Medical License 2012 - 2025
NY State Medical License 1999 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Boston Magazine Castle Connolly, 2013
- Top Doctors: New York Metro Area Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC Start of enrollment: 2005 Nov 01
- Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer Start of enrollment: 2003 Jan 01
- Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer Start of enrollment: 2002 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 150 citationsBasic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.Henning Willers, Christopher G. Azzoli, Wil L. Santivasi, Fen Xia
Cancer Journal. 2013-05-01 - 163 citationsEvolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer.Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris
Nature Reviews. Clinical Oncology. 2021-04-28 - 223 citationsAdjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Can...Mark G. Kris, Laurie E. Gaspar, Jamie E. Chaft, Erin B. Kennedy, Christopher G. Azzoli
Journal of Clinical Oncology. 2017-04-24
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationR S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
Press Mentions
Roche’s IMpower010 Trial Results Warrant Evidence on Survival Impact for Tecentriq Adoption in Non-Small Cell Lung CancerJune 2nd, 2021
Merck’s Proposed Less Frequent Keytruda Dosing May Allow for Minor Uptake BoostNovember 19th, 2019
Committees
- Member (Steering committee), Update Committee of the ASCO NSCLC Expert Panel, American Society of Clinical Oncology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
